截至6月30日，华鲁恒升股东户数5.27万，较上期减少15.20%；人均流通股40209股，较上期增加 18.12%。2025年1月-6月，华鲁恒升实现营业收入157.64亿元，同比减少7.14%；归母净利润15.69亿元， 同比减少29.47%。 资料显示，山东华鲁恒升化工股份有限公司位于山东省德州市天衢西路24号，成立日期2000年4月26 日，上市日期2002年6月20日，公司主营业务涉及尿素、甲醇的生产和销售。主营业务收入构成为：新 能源新材料相关产品48.34%，化学肥料24.61%，醋酸及衍生品10.82%，其他产品7.75%，有机胺 7.33%，副产品及其他1.15%。 华鲁恒升所属申万行业为：基础化工-农化制品-氮肥。所属概念板块包括：社保重仓、化肥、煤化工、 MSCI中国、大盘等。 9月29日，华鲁恒升盘中上涨2.04%，截至13:13，报26.05元/股，成交2.18亿元，换手率0.40%，总市值 553.10亿元。 资金流向方面，主力资金净流出333.33万元，特大单买入606.78万元，占比2.78%，卖出1168.19万元， 占比5.35%；大单买入3703.54万元，占比16.95 ...

9月29日，三孚股份盘中上涨2.03%，截至11:23，报14.05元/股，成交2417.74万元，换手率0.45%，总市 值53.76亿元。 资金流向方面，主力资金净流入153.72万元，大单买入373.62万元，占比15.45%，卖出219.90万元，占 比9.10%。 截至6月30日，三孚股份股东户数2.48万，较上期减少4.99%；人均流通股15447股，较上期增加5.25%。 2025年1月-6月，三孚股份实现营业收入10.08亿元，同比增长11.18%；归母净利润3845.84万元，同比减 少5.60%。 分红方面，三孚股份A股上市后累计派现2.24亿元。近三年，累计派现1.02亿元。 责任编辑：小浪快报 今年以来三孚股份已经3次登上龙虎榜，最近一次登上龙虎榜为4月21日。 资料显示，唐山三孚硅业股份有限公司位于河北省唐山市南堡开发区希望路512号，成立日期2006年10 月20日，上市日期2017年6月28日，公司主营业务涉及三氯氢硅及氢氧化钾等精细化工产品的研发、生 产和销售。主营业务收入构成为：钾系列56.54%，硅烷偶联剂26.33%，硅系列14.39%，其他2.74%。 三孚股份所属申万 ...

截至6月30日，盐湖股份股东户数20.10万，较上期减少6.24%；人均流通股26327股，较上期增加 6.66%。2025年1月-6月，盐湖股份实现营业收入67.81亿元，同比减少6.30%；归母净利润25.15亿元，同 比增长13.69%。 分红方面，盐湖股份A股上市后累计派现53.06亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年6月30日，盐湖股份十大流通股东中，香港中央结算有限公司位居第八大流 通股东，持股1.26亿股，相比上期增加2761.17万股。 责任编辑：小浪快报 资金流向方面，主力资金净流入89.80万元，特大单买入4045.04万元，占比8.99%，卖出7183.72万元， 占比15.97%；大单买入1.38亿元，占比30.65%，卖出1.06亿元，占比23.48%。 盐湖股份今年以来股价涨21.51%，近5个交易日涨2.15%，近20日跌0.30%，近60日涨16.82%。 资料显示，青海盐湖工业股份有限公司位于青海省格尔木市黄河路28号，成立日期1997年8月25日，上 市日期1997年9月4日，公司主营业务涉及钾肥和锂盐的开发、生产和销售。主营业务收入构成为：钾产 ...

Core Viewpoint - Hongda Co., Ltd. experienced a stock price decline of 2.06% on September 26, with a current price of 9.99 CNY per share and a total market capitalization of 26.39 billion CNY [1] Financial Performance - For the first half of 2025, Hongda Co., Ltd. reported revenue of 1.81 billion CNY, representing a year-on-year growth of 2.80%, while the net profit attributable to shareholders was -74.99 million CNY, a decrease of 228.54% compared to the previous period [2] Stock Market Activity - As of September 26, 2023, the stock has increased by 31.10% year-to-date, but has seen a decline of 12.60% over the last five trading days and 9.02% over the last twenty days [1] - The stock's trading volume on September 26 was 357 million CNY, with a turnover rate of 1.73% [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Hongda Co., Ltd. was 58,400, a decrease of 4.16% from the previous period, while the average number of circulating shares per shareholder increased by 4.34% to 34,823 shares [2][3] Dividend History - Since its A-share listing, Hongda Co., Ltd. has distributed a total of 1 billion CNY in dividends, but has not issued any dividends in the past three years [3] Major Shareholders - As of June 30, 2025, the sixth largest circulating shareholder is Shenwan Hongyuan Securities Co., Ltd., holding 34.18 million shares, an increase of 277,200 shares from the previous period [3]

Core Viewpoint - The company Suhao Hongye experienced a decline in stock price and trading volume, indicating potential market challenges and investor sentiment issues [1] Company Overview - Suhao Hongye Co., Ltd. is located in Nanjing, Jiangsu Province, and was established on June 30, 1994, with its stock listed on September 1, 1997 [6] - The company's main business includes trade (import and export, domestic trade) and cultural services (cultural engineering, art management, cultural venue operations, and cultural creative product development and sales) [6] - The revenue composition is as follows: 98.45% from product sales, 1.05% from engineering projects and consulting services, and 0.51% from other sources [6] Financial Performance - For the first half of 2025, Suhao Hongye achieved a revenue of 3.919 billion yuan, representing a year-on-year growth of 10.73% [6] - The net profit attributable to the parent company was 26.2955 million yuan, showing a year-on-year increase of 34.72% [6] - The company has distributed a total of 503 million yuan in dividends since its A-share listing, with 74.0302 million yuan distributed in the last three years [7] Investment and Shareholding - The company holds a 16.31% stake in Hongye Futures, which is the second-largest shareholder, and Hongye Futures is listed on the Hong Kong Stock Exchange [2] - Suhao Hongye's subsidiary, Jiangsu Aitao Cultural Industry Co., Ltd., holds a 28% stake in Jiangsu Cultural Property Exchange Co., Ltd. [2] - The company invested 12 million yuan for a 24% stake in Jiangsu Hongrui Technology Investment Co., Ltd., the first venture capital firm in Jiangsu Province focused on the biopharmaceutical sector [2] Market Activity - On September 25, the stock price of Suhao Hongye fell by 1.65%, with a trading volume of 44.5315 million yuan and a turnover rate of 1.76%, resulting in a total market capitalization of 2.507 billion yuan [1] - The main capital flow showed a net outflow of 4.8943 million yuan, indicating a lack of strong buying interest from major investors [3][4] Technical Analysis - The average trading cost of the stock is 10.88 yuan, with recent reductions in shareholding but at a slowing rate [5] - The current stock price is near a resistance level of 10.42 yuan, suggesting potential for a pullback unless this level is breached, which could lead to an upward trend [5]

9月25日，华尔泰盘中下跌2.03%，截至13:46，报11.56元/股，成交4510.60万元，换手率1.18%，总市值 38.36亿元。 资金流向方面，主力资金净流出318.86万元，特大单买入0.00元，占比0.00%，卖出103.16万元，占比 2.29%；大单买入332.67万元，占比7.38%，卖出548.38万元，占比12.16%。 华尔泰今年以来股价跌17.61%，近5个交易日跌1.45%，近20日跌0.17%，近60日跌3.34%。 今年以来华尔泰已经1次登上龙虎榜，最近一次登上龙虎榜为3月28日，当日龙虎榜净买入-402.68万 元；买入总计1.15亿元 ，占总成交额比12.59%；卖出总计1.19亿元 ，占总成交额比13.03%。 资料显示，安徽华尔泰化工股份有限公司位于安徽省池州市东至县香隅镇，成立日期2000年1月5日，上 市日期2021年9月29日，公司主营业务涉及致力于化工产品的研发、生产与销售。主营业务收入构成 为：大宗化学品73.85%，其他11.04%，化工中间体10.43%，氨基树脂系列4.68%。 责任编辑：小浪快报 华尔泰所属申万行业为：基础化工-化学原料-其他化学原 ...

Company Overview - Chuanjinnuo Chemical Co., Ltd. is located in Kunming, Yunnan Province, and was established on June 2, 2005, with its listing date on March 15, 2016 [1] - The company specializes in the research, production, and graded utilization of wet-process phosphoric acid, as well as the production and sales of phosphates [1] - The main revenue composition includes phosphoric acid (51.36%), feed-grade phosphates (23.92%), phosphate fertilizers (22.87%), and others (1.85%) [1] Financial Performance - As of June 30, the number of shareholders for Chuanjinnuo is 35,300, a decrease of 2.12% from the previous period, with an average of 6,150 circulating shares per person, an increase of 2.16% [2] - For the first half of 2025, the company achieved operating revenue of 1.744 billion yuan, a year-on-year increase of 27.91%, and a net profit attributable to shareholders of 177 million yuan, a year-on-year increase of 166.51% [2] Stock Performance - On September 25, Chuanjinnuo's stock price increased by 2.00%, reaching 19.85 yuan per share, with a trading volume of 44.26 million yuan and a turnover rate of 1.04%, resulting in a total market capitalization of 5.456 billion yuan [1] - Year-to-date, the stock price has risen by 40.78%, with a 1.22% increase over the last five trading days, a 3.87% decrease over the last 20 days, and a 7.12% increase over the last 60 days [1] Dividend Information - Since its A-share listing, Chuanjinnuo has distributed a total of 207 million yuan in dividends, with 113 million yuan distributed over the past three years [3]

Core Viewpoint - Yara International's stock price has shown significant growth this year, with a 90.28% increase, indicating strong market performance and investor interest [1][2]. Financial Performance - For the first half of 2025, Yara International reported a revenue of 2.522 billion yuan, representing a year-on-year growth of 48.54% [2]. - The net profit attributable to shareholders for the same period was 855 million yuan, marking a substantial increase of 216.64% compared to the previous year [2]. Stock Market Activity - As of September 25, Yara International's stock was trading at 38.36 yuan per share, with a market capitalization of 35.447 billion yuan [1]. - The stock has experienced a recent trading volume of 86.8992 million yuan, with a turnover rate of 0.28% [1]. - The stock has seen a net outflow of 132,000 yuan in principal funds, while large orders accounted for 12.44% of buying and 13.38% of selling [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Yara International increased to 26,500, up by 8.88% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 8.15% to 30,593 shares [2]. Dividend History - Yara International has cumulatively distributed 85.8774 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder, holding 13.8236 million shares as a new shareholder [3]. - The Southern CSI 500 ETF was the ninth-largest circulating shareholder, with a reduction of 179,300 shares compared to the previous period [3].

责任编辑：小浪快报 资料显示，湖北兴发化工集团股份有限公司位于湖北省宜昌市伍家岗区沿江大道188-9号兴发大厦，成 立日期1994年8月17日，上市日期1999年6月16日，公司主营业务涉及从事磷矿石的开采及销售,磷酸 盐、磷肥、草甘膦、有机硅等化工产品的生产和销售以及贸易业务。主营业务收入构成为：特种化学品 17.88%，农药17.57%，商贸物流17.19%，其他14.22%，肥料13.16%，矿山采选10.60%，有机硅系列 9.37%。 兴发集团所属申万行业为：基础化工-农化制品-磷肥及磷化工。所属概念板块包括：草甘膦、生物农 药、磷化工、化肥、氟化工等。 截至9月10日，兴发集团股东户数4.90万，较上期减少1.19%；人均流通股22537股，较上期增加1.21%。 2025年1月-6月，兴发集团实现营业收入146.20亿元，同比增长9.07%；归母净利润7.27亿元，同比减少 9.72%。 分红方面，兴发集团A股上市后累计派现48.14亿元。近三年，累计派现28.69亿元。 机构持仓方面，截止2025年6月30日，兴发集团十大流通股东中，南方中证500ETF（510500）位居第七 大流通股东，持 ...

Company Overview - Zhejiang Dayang Biological Technology Group Co., Ltd. is located in Hangzhou, Zhejiang Province, and was established on January 1, 1976. The company was listed on October 26, 2020. Its main business involves the production and sales of chemical raw materials, including inorganic salts and veterinary raw materials [2]. Financial Performance - As of June 30, the company reported a revenue of 499 million yuan for the first half of 2025, representing a year-on-year growth of 14.20%. The net profit attributable to the parent company was 50.51 million yuan, showing a significant increase of 60.66% year-on-year [2]. - The company has distributed a total of 168 million yuan in dividends since its A-share listing, with 97.57 million yuan distributed over the past three years [3]. Stock Performance - Year-to-date, the stock price of Dayang Biological has increased by 79.60%. However, it has experienced a decline of 4.05% over the last five trading days and 5.43% over the last 20 days. In contrast, the stock has risen by 29.06% over the past 60 days [2]. - As of September 22, the stock price was 32.91 yuan per share, with a market capitalization of 2.764 billion yuan. The trading volume was 45.52 million yuan, with a turnover rate of 1.97% [1]. Shareholder Information - As of June 30, the number of shareholders increased to 14,200, reflecting a growth of 58.33%. The average number of circulating shares per shareholder decreased by 35.82% to 4,954 shares [2]. Business Segmentation - The company's main business revenue composition includes: 69.91% from inorganic salt products, 18.35% from veterinary raw materials, 7.46% from fluorine chemical products, and 4.28% from other products [2]. - Dayang Biological is classified under the Shenwan industry as basic chemicals - chemical raw materials - inorganic salts, and is associated with concepts such as fertilizers, biopesticides, fluorine chemicals, share buybacks, and synthetic biology [2].